Related Experiment Video
Updated: Dec 17, 2025

07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.9K
Fatty Acid Mediators in the Tumor Microenvironment
Saraswoti Khadge1,2, John Graham Sharp3, Geoffrey M Thiele1,4,5
1Department of Pathology and Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Advances in Experimental Medicine and Biology
|June 25, 2020
Summary
Dietary omega-3 polyunsaturated fatty acids (ω-3 PUFA) may reduce cancer-promoting inflammation and improve survival. The balance of omega-3 vs. omega-6 PUFA impacts tumor growth, metastasis, and overall survival.
Area of Science:
- Oncology
- Nutrition Science
- Immunology
Background:
- Cancer patients often exhibit elevated inflammatory cytokines and neutrophilia.
- Omega-3 polyunsaturated fatty acids (ω-3 PUFA) possess anti-inflammatory properties with potential anticancer effects.
- Obesity and dietary fatty acid intake are often conflated in research on inflammation and cancer progression.
Purpose of the Study:
- To explore the intricate relationships between dietary lipids, inflammation, and neoplasia.
- To investigate strategies for modulating these relationships through diet.
- To highlight the role of dietary lipid composition, specifically the ω-3/ω-6 PUFA ratio, in cancer development and patient survival.
Main Methods:
- Review of existing literature on dietary lipids, inflammation, and cancer.
- Analysis of lipid mediators that bridge inflammation and cancer.
- Examination of dietary lipid regulation in murine and human tumor models.
Main Results:
- Dietary lipids, particularly the ω-3/ω-6 PUFA ratio, are implicated in regulating chronic inflammation.
- Specific lipid mediators link inflammatory processes to cancer initiation, progression, and regression.
- Dietary lipid composition influences tumor initiation, progression, metastasis frequency, and sites.
Conclusions:
- Dietary composition, especially the ω-3 vs. ω-6 PUFA ratio, is a critical factor in controlling tumor growth and metastasis.
- Modulating dietary lipids offers a potential strategy to impact cancer progression and patient survival.
- Further research differentiating obesity and dietary fatty acid effects is warranted.
Related Concept Videos
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Tumor Immunotherapy
1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K

